Martin Shkreli Is Removed as C.E.O of KBIO

No surprises here, KBIO stock still not open, but you can bet it will not be pretty.

SOUTH SAN FRANCISCO, Calif., Dec. 21, 2015 /PRNewswire/ -- KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO), today announced that on December 17, 2015, Martin Shkreli was terminated as Chief Executive Officer of the Company and resigned from his position as a member of the board of directors. In addition, on December 17, 2015, Tony Chase resigned from his position as a member of the board of directors.

Submitted December 21, 2015 at 10:52AM by StockJock-e http://ift.tt/1NyrZ24